‘Electrosurgical Energy Devices Market Worth Over $3.6 Billion In 2017’ Says Visiongain Report

23 August 2017
Pharma

Visiongain’s new report The Global Electrosurgical Energy Devices Market : Revenue Prospects by Product (Electrosurgical Generators, Instruments and Accessories, Argon and Smoke Management Systems), Application (General, Gynaecologic, Urologic, Orthopaedic, Cardiovascular, Cosmetic and Neurosurgery) and Geography indicates that the Electrosurgical Energy Devices market will see over $3.6bn in revenue in 2017.
The lead analyst of the report said:

“The market for electrosurgical energy devices is driven by the increase in geriatric population, increased demand for technologically advanced procedures, an increase in minimally invasive procedures, and the general increase in the number of surgical procedures worldwide. However, certain factors such as stringent government regulation are expected to restrain the market during the forecast period.

The electrosurgical energy devices market is also driven by top players such as Medtronic Plc, Johnson and Johnson, Olympus Corporation and Others. The key strategies adopted by the key players in this industry includes product approval, launch, & enhancement; acquisitions & mergers; agreements & collaborations; and expansion. Product approval, launch, & enhancement was the most commonly adopted strategy by the leading players in electrosurgical devices market in the period of January 2014-November 2016.”

The 157-page report contains 170 tables, charts and graphs that add visual analysis in order to explain developing trends within the Electrosurgical Energy Devices. Visiongain provides revenue forecasts for the period 2017-2027 for the leading Electrosurgical Energy Device submarkets, segmented by product, with forecasts for Electrosurgical Generators, Instruments, Accessories and Argon and Smoke Management Systems. Included in the Electrosurgical Instruments segment are forecasts for Bipolar Instruments (including forecasts for Advanced Vessel Sealing Instruments and Bipolar Forceps) and Monopolar Instruments (including forecasts for Patient Return Electrodes, Cords, Cables and Adapters and Others) The market is also segmented by application, and includes forecasts for General Surgery, Gynaecologic Surgery, Urologic Surgery, Orthopaedic Surgery, Cardiovascular Surgery, Cosmetic Surgery, Neurosurgery and Others.

The 157-page report offers market forecasts and analysis for 19 national markets. In addition, the report contains a dedicated leading companies’ chapter covering 10 companies leading the field in Electrosurgical Energy Device technology in detail.

The Electrosurgical Energy Devices Market Forecast, 2017-2027: Revenue Prospects by Product (Electrosurgical Generators, Instruments and Accessories, Argon and Smoke Management Systems), Application (General, Gynaecologic, Urologic, Orthopaedic, Cardiovascular, Cosmetic and Neurosurgery) and Geography report will be of value to anyone who wants to better understand the electrosurgical energy device market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the electrosurgical energy device industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

Read

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

Read

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

Read

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever